NOVARTIS
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people's lives. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy.
NOVARTIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1970
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novartis.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 324 11 11
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins
Revenue:
51.83 BTotal Assets:
117.45 BTotal Cash:
7.52 B
Similar Organizations
Abomics
Abomics Ltd is an expert company that promotes the application of medical research to patient care.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
MedCompared
MedCompared is a health comparison site that helps you to choose your prescribed medication for the best price in the best online pharmacy.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Novartis India
Novartis India is a healthcare company that address needs and deliver better patient outcomes.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
PharmaLead
PharmaLead is a healthcare company that advises and improves pharmacies in the re-design of business processes and business operations.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Novartis AG (NVS)
Last Price
96.40$Change
-0.15$ (-0.16%)Volume
3.25M| Previous Close | 96.55 |
| Open | 96.19 |
| Day Range | 95.34-96.49 |
| Bid | 0.00 x 1.4k |
| Ask | 0.00 x 800 |
| Volume | 3.25M |
| Average Volume | 2.15M |
| Market Cap | 204.33B |
| Beta | 0.47 |
| 52 Week Range | 74.09-105.56 |
| Trailing P/E | 29.57 |
| Foward P/E | 13.19 |
| Dividend (Yield %) | 3.62% |
| Ex-Dividend Date | 2023-03-09 |
Financial Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-22 | Gyroscope Therapeutics | Gyroscope Therapeutics acquired by Novartis | 1.5 B USD |
| 2021-09-17 | Arctos Medical | Arctos Medical acquired by Novartis | N/A |
| 2021-06-01 | Cellerys | Cellerys acquired by Novartis | N/A |
| 2020-12-17 | Cadent Therapeutics | Cadent Therapeutics acquired by Novartis | 770 M USD |
| 2020-10-29 | Vedere Bio ll | Vedere Bio ll acquired by Novartis | 280 M USD |
| 2020-04-20 | Amblyotech | Amblyotech acquired by Novartis | N/A |
| 2019-11-24 | The Medicines Company | The Medicines Company acquired by Novartis | 9.7 B USD |
| 2019-05-09 | Xiidra | Xiidra acquired by Novartis | 1.9 B USD |
| 2018-12-21 | CellforCure | CellforCure acquired by Novartis | N/A |
| 2018-10-18 | Endocyte | Endocyte acquired by Novartis | N/A |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novartis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Novartis investment in Series A - Aktis Oncology | 84 M USD |
| 2022-07-25 | Cleerly | Novartis investment in Series C - Cleerly | 223 M USD |
| 2022-06-22 | Alladapt Immunotherapeutics | Novartis investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2022-05-19 | Deciphex | Novartis investment in Series B - Deciphex | 11.5 M USD |
| 2022-03-04 | Klarah | Novartis investment in Grant - Klarah | 20 K USD |
| 2022-03-04 | Parrots | Novartis investment in Pre Seed Round - Parrots | 100 K USD |
| 2021-12-07 | Freenome | Novartis investment in Series D - Freenome | 300 M USD |
| 2021-12-06 | Holmusk | Novartis investment in Venture Round - Holmusk | N/A |
| 2021-12-02 | Medtech Africa | Novartis investment in Grant - Medtech Africa | 20 K USD |
| 2021-11-09 | Mekonos | Novartis investment in Series A - Mekonos | 25 M USD |
Newest Events participated
Participated in Webit Festival Europe
on 2020-06-17 as sponsor
Key Employee Changes
Official Site Inspections
http://www.novartis.com Semrush global rank: 104.19 K Semrush visits lastest month: 941 K
- Host name: 104.18.0.16
- IP address: 104.18.0.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novartis" on Search Engine
Novartis Canada
Healthcare Professionals Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs. Careers Our work has touched the lives of millions of Canadians. Novartis 2022 Financial ResultsSee details»
About | Novartis
Products Learn more about treatments currently offered by Novartis Innovative Medicines, Sandoz and Advanced Accelerator Applications. Our vision is to become the most valued …See details»
Novartis
May 11, 2023 Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.See details»
Novartis Medical Information | Novartis
Novartis Medical Information is committed to providing the most up‑to‑date, accurate, and balanced scientific information regarding Novartis products. Select your region from the …See details»
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research). Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.See details»
Products | Novartis
Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan Azarga®/Azorga® (brinzolamide, timolol) Ophthalmology Germany Australia Austria …See details»
Coronavirus | Novartis
Novartis has been responding to the coronavirus disease (COVID-19) with safety of associates and patients globally as our primary concern. We have been also contributing …See details»
Investors | Novartis
Investors. Creating value for our company, our shareholders and society. We aim for sustainable performance over time to benefit patients, employees, shareholders and …See details»
Novartis PSI Report | Novartis
Novartis Medical Information Submit medical enquiry Healthcare Professionals. Resources for physicians and other healthcare professionals including clinical trial recruiting, grant …See details»
Former Novartis executive director heads up Larkspur, …
May 23, 2023 Catherine Sabatos-Peyton's last startup was only in operation for about a year before Novartis AG scooped it up for a cool $248 million. Now, after about five …See details»
Locations | Novartis
Novartis Medical Information Submit medical enquiry Healthcare Professionals. Resources for physicians and other healthcare professionals including clinical trial recruiting, grant …See details»
Medical Information | Pro.Novartis.ca
Phone : 1-800-363-8883 Email : [email protected] Adverse Events Reporting Phone : 1-877-631-6775 (ext - 3425) Fax : 1-877-636-3175 (ext - 3425) Email: …See details»
Novartis | LinkedIn
Novartis | 3,491,616 followers on LinkedIn. Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative …See details»
Home | Novartis United States of America
Latest News Mar 28, 2023 Novartis ribociclib (Kisqali®) only Category 1 preferred first-line treatment option for HR+/HER2- mBC in combination with an AI in updated NCCN …See details»
Careers | Novartis
Early Careers. We may be a pharmaceutical company, but you do not need a science degree to start your career here. We believe diversity is the key driver to innovation and …See details»
Novartis Products | Novartis Oncology Patient Support
Our Commitment to Patients Novartis Oncology Products Below is a list of the medications we currently offer.See details»
Ask Novartis Pharma - Canada - Medical Information Service
Contact Us Need to contact us? If you are unable to find an answer to your question and would like to contact us, please email us or call 1-800-363-8883. Medical Information is …See details»
EMA urges revoking approval for Novartis sickle cell drug - STAT
May 26, 2023 The U.S. Food and Drug Administration granted full approval to Paxlovid, the Pfizer Covid-19 pill, clearing the way for the company to sell the drug …See details»
Novartis gets EMA review for biosimilar to Amgen's Prolia, Xgeva
May 25, 2023 The Novartis unit is also heading for a spin-off and the Swiss pharma giant is on track to make it happen in H2 2023. A 10-member board for the generics unit was …See details»
Novartis Oncology for Health Care Professionals
Access Start a benefits investigation and receive information on your patients' financial support options. Care Management Browse our resources for health system or managed …See details»